ENTITY
Mega Genomics

Mega Genomics (6667 HK)

3
Analysis
Health Care • China
Mega Genomics is a genetic testing platform company in China that focuses on consumer genetic testing and cancer screening services. The company offers a wide range of testing services, including those for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, and infectious disease diagnosis. It also provides in vitro diagnostics (IVD) pipeline products. Mega Genomics is headquartered in Beijing, China, and was founded in 2016.
more
bullish•Mega Genomics
•09 Aug 2026 04:20

Primer: Mega Genomics (6667 HK) - Aug 2026

Mega Genomics is positioned to capitalize on the rapid expansion of China's genetic testing market, which is driven by rising health awareness,...

Logo
92 Views
Share
No more insights
x